1 / 4

Carcinoembryonic Antigen Market Research Report - Global Forecast Till 2023

Carcinoembryonic Antigen Market Research Report - Global Forecast Till 2023

Rohitravan
Download Presentation

Carcinoembryonic Antigen Market Research Report - Global Forecast Till 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Carcinoembryonic Antigen Market is Expected to Grow at a CAGR of 6.7% by 2023 Market Highlights Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician. In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth. Avail a FREE Sample@ https://www.marketresearchfuture.com/sample_request/7620 Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period. Market Players Some of key players profiled in the report areLee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC. Regional Analysis The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period. Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period. | Market Research Future |

  2. On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest. The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health. Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023. Segmentation The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user. Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others. Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others. Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others. Access Complete Report @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772 TABLE OF CONTENTS 1. REPORT PROLOGUE 2. MARKET INTRODUCTION 2.1. Definition 2.2. Scope Of The Study 2.2.1. Research Objective 2.2.2. Assumptions 2.2.3. Limitations 3. RESEARCH METHODOLOGY 3.1. Overview 3.2. Primary Research 3.3. Secondary Research 3.4. Market Size Estimation | Market Research Future |

  3. 4. MARKET DYNAMICS 4.1. Overview 4.2. Drivers 4.3. Restraints 4.4. Opportunities 5. MARKET FACTOR ANALYSIS 5.1. Porter’s Five Forces Analysis 5.1.1. Bargaining Power Of Suppliers 5.1.2. Bargaining Power Of Buyers 5.1.3. Threat Of New Entrants 5.1.4. Threat Of Substitutes 5.1.5. Intensity Of Rivalry 5.2. Value Chain Analysis 5.2.1. R&D And Designing 5.2.2. Manufacturing 5.2.3. Distribution & Sales 5.2.4. Post Sales Services 6. GLOBAL CARCINOEMBRYONIC ANTIGEN MARKET, BY APPLICATION 6.1. Overview 6.2. Colorectal Cancer Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 6.3. Pancreatic Cancer Market Estimates & Forecast, By Region, 2019–2025 Market Estimates & Forecast, By Country, 2019–2025 Continued… About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: | Market Research Future |

  4. Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com | Market Research Future |

More Related